The search is formally on for the next head of the European Medicines Agency. A vacancy notice for an executive director of the agency, to take office on 1 January 2011 after the departure of Thomas Lönngren at the end of this year, was advertised on 15 January1.
As well as regulating human and veterinary medicines, the EMA regulates advanced therapies such as tissue engineering and gene-based treatments...
Please login to read the full article.
